Display options
Share it on

Front Immunol. 2017 Apr 05;8:326. doi: 10.3389/fimmu.2017.00326. eCollection 2017.

Mucosal and Systemic Immune Responses to Influenza H7N9 Antigen HA1-2 Co-Delivered Intranasally with Flagellin or Polyethyleneimine in Mice and Chickens.

Frontiers in immunology

Li Song, Dan Xiong, Hongqin Song, Lili Wu, Meihua Zhang, Xilong Kang, Zhiming Pan, Xinan Jiao

Affiliations

  1. Jiangsu Co-Innovation Center for Prevention and Control of Important Animal Infectious Diseases and Zoonoses, Yangzhou, China.
  2. Jiangsu Key Laboratory of Zoonosis, Yangzhou University, Yangzhou, China.
  3. Key Laboratory of Prevention and Control of Biological Hazard Factors (Animal Origin) for Agrifood Safety and Quality, Ministry of Agriculture of China, Yangzhou University, Yangzhou, China.
  4. Joint International Research Laboratory of Agriculture and Agri-Product Safety of the Ministry of Education, Yangzhou, China.

PMID: 28424686 PMCID: PMC5380672 DOI: 10.3389/fimmu.2017.00326

Abstract

Consecutive cases of human infection with H7N9 influenza viruses since 2013 in China have prompted efforts to develop an effective treatment. Subunit vaccines introduced by intranasal administration can block an infection at its primary site; flagellin (fliC) and polyethyleneimine (PEI) have been shown to be potent adjuvants. We previously generated the hemagglutinin (HA)1-2-fliC fusion protein consisting of the globular head domain (HA1-2; amino acids 62-284) of HA fused with

Keywords: avian influenza A (H7N9) virus; flagellin; hemagglutinin globular head; mucosal subunit vaccine; polyethyleneimine

References

  1. N Engl J Med. 2007 Feb 15;356(7):685-96 - PubMed
  2. Immunol Rev. 1999 Aug;170:183-96 - PubMed
  3. Vaccine. 2012 Jan 5;30(2):466-74 - PubMed
  4. Pharm Res. 2014 Oct;31(10):2748-61 - PubMed
  5. Vaccine. 2009 Sep 25;27(42):5875-84 - PubMed
  6. PLoS One. 2015 Sep 10;10(9):e0137608 - PubMed
  7. PLoS One. 2016 Mar 01;11(3):e0150678 - PubMed
  8. Vaccine. 2003 Sep 8;21(25-26):3801-14 - PubMed
  9. Methods. 2003 Nov;31(3):207-16 - PubMed
  10. J Infect Dis. 1993 Nov;168(5):1282-5 - PubMed
  11. Infect Immun. 2004 Nov;72(11):6676-9 - PubMed
  12. Vaccine. 2011 Aug 5;29(34):5666-74 - PubMed
  13. Vaccine. 2015 Aug 20;33(35):4321-9 - PubMed
  14. Protein Expr Purif. 2006 Jul;48(1):61-8 - PubMed
  15. Jpn J Clin Oncol. 2012 Jan;42(1):36-41 - PubMed
  16. J Immunol. 2008 May 1;180(9):6159-67 - PubMed
  17. Immunol Res. 2004;30(1):35-71 - PubMed
  18. PLoS One. 2009 Jun 24;4(6):e6032 - PubMed
  19. Drugs. 2011 Mar 5;71(4):465-88 - PubMed
  20. Vaccine. 2012 Nov 6;30(48):6833-8 - PubMed
  21. Vaccine. 2007 Sep 28;25(39-40):6975-80 - PubMed
  22. PLoS One. 2008 May 21;3(5):e2257 - PubMed
  23. Vaccine. 2011 Apr 12;29(17):3341-55 - PubMed
  24. PLoS One. 2011;6(6):e20928 - PubMed
  25. Vaccine. 2016 Sep 14;34(40):4807-13 - PubMed
  26. Vaccine. 2003 Jul 4;21(23):3097-100 - PubMed
  27. Adv Drug Deliv Rev. 2012 May 1;64(6):523-30 - PubMed
  28. Br Med J. 1977 Mar 12;1(6062):686 - PubMed
  29. Vet Microbiol. 2012 May 25;157(1-2):69-77 - PubMed
  30. Nat Biotechnol. 2012 Sep;30(9):883-8 - PubMed
  31. J Immunol. 2011 Jan 15;186(2):987-93 - PubMed
  32. J Infect Dis. 2013 Jan 1;207(1):115-24 - PubMed
  33. PLoS One. 2015 Jun 09;10(6):e0128785 - PubMed
  34. Int Immunol. 2014 Oct;26(10):531-8 - PubMed
  35. Lancet. 2013 Jun 1;381(9881):1916-25 - PubMed
  36. BMC Biotechnol. 2015 Aug 19;15:79 - PubMed
  37. BioDrugs. 2011 Aug 1;25(4):217-26 - PubMed
  38. Hum Vaccin Immunother. 2015;11(5):1235-43 - PubMed

Publication Types